March 01, 2007
Genentech sends “dear doctor” letters
Genentech has sent a “dear doctor” letter to warn about a higher risk for stroke in patients taking 0.5 mg of Lucentis, indicated for treating wet age-related macular degeneration.
Congress has finally passed the Right to Try Act, but does it go far enough?
The government agency released its latest guidance this week.
11 questions for the GW CEO on the watershed moment.